Nomination Committee appointed before the annual general meeting of Bioservo 2019
In line with the decision taken during the meeting on May 2nd, 2018, Bioservo's Chairman of the Board has contacted the company's largest owners to form a nomination committee. Counted as an owner is also a group of two or more shareholders (shareholder group) if they have notified the Chairman of the Board that they wish to participate in the work of the nomination committee together.
The following shareholders and representatives are part of the Nomination Committee, in addition to Chairman Anders Lundmark:
- Runar Bjørklund, nominated by Tellacq AB
- Simon Josefsson, nominated by Simon Josefsson Datakonsult AB
- Tomas Ward, representing his private holding
The Nomination Committee shall submit proposals to the Chairman of the Annual General Meeting 2019 regarding the following:
- Proposal for members of the Board of Directors
- Proposal for the auditor
- Proposal for the Chairman of the Board
- Proposal regarding the Board remuneration, divided for the chairman and for other members of the
board as well as remuneration for committee work
- Proposed remuneration to the auditor
- Proposal for Chairman of the Annual General Meeting
- Guidelines for appointment of the election committee
Shareholders who wish to submit proposals to the Nomination Committee for the Annual General Meeting 2019 may do so to the Nomination Committee no later than 28 February 2019 by emailing to valberedningen@bioservo.com or by posting a letter addressed to Bioservo Technologies AB, Nomination Committee, Torshamnsgatan 35, 164 40 Kista.
Bioservo Technologies AB
About Bioservo Technologies AB
Bioservo Technologies (publ) is a technology and development company that combines medical science with modern robotics. The company has a leading global position within soft exoskeleton technology, wearable non-invasive products, for people in need of extra power to support the body's endurance and performance, or for people with reduced muscular strength.
After many years of research and development, Bioservo Technologies now focuses on the commercialization of its products and patented technologies. The developed gloves are well suited for both rehabilitation within health and medical care as well as preventively for professionals in the industry. The company has signed strategic cooperation agreements with several multinational companies within e.g. the automobile, aircraft as well as the construction and infrastructure industry.
Bioservo Technologies was founded in 2006 through a collaboration between researchers at the Royal Institute of Technology and doctors at Karolinska University Hospital in Stockholm. Bioservo Technologies is a Swedish public company with headquarters and operations in Kista, north of Stockholm. FNCA Sweden AB is the company's Certified Adviser on Nasdaq First North.
For more information, please visit www.bioservo.com